Brighter and Telia sign agreement for subscription services for the Actiste diabetes solution.
The deal means that Brighter’s connected diabetes management solution for insulin-treated diabetes patients, Actiste®, will be available on the Swedish market through Telia’s digital healthcare solution. The deal with Telia, like the partnership initiated with Ericsson in 2015, is an important milestone towards Brighter’s vision for the future of healthcare, and it allows Brighter to move towards the design of a joint launch plan for Actiste. “Of course we are very happy to finally have a first mobile operator agreement in place. It is clear that Telia shares our vision and idea about
